NP89
NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
11/10/2025
Back to search
Official data from USPTO
NEURIMMUNE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEURIMMUNE
ST13
US500000085683759Class
1, 5, 42, 44
Filing
85683759
Registration
4788066
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
103
Latest update
12/02/2025
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
07/22/2012
Registration date
08/11/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/10/2025
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Schlieren, CH
Examiner
LEHKER,DAWN FELDMAN
Holders and representatives
Holders
Neurimmune Holding AG
Representatives
Janice Housey Litmus Law PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases; industrial chemicals; chemical preparations for scientific purposesother than for medical or veterinary purposes; chemical preparations for use in photography; biological preparations for use in cell cultures other than for medical or veterinary purposes; biomedical compoundspeptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biochemicalssynthetic polypeptides made from amino acids that do not derive from animals for use in diagnostic and therapeutic agents
Class 5
Pharmaceutical preparations to treat diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; veterinary preparations to treat diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodiesbuffers and reagents for use in disease testing; biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases; synthetic peptides for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; biological preparations for the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; sanitary preparations for medical use; biocides; diagnostic preparations for medical and veterinary use; sanitary towels; dietetic foodgluten-free foodlow-sodium foodlow-calorie or reduced calorie food for weight reduction adapted for medical purposesdietetic bread and dietetic noodles; dietetic beveragesgluten-free beverageslow-sodium beveragesdietetic tea; low calorie or reduced-calorie beverages for weight reduction adapted for medical purposeslow calorie or reduced calorie fruit beverages: protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases
Class 42
Testinginspection or research of pharmaceuticalscosmetics or foodstuffs; consultation and providing information about testinginspection or research of pharmaceuticalscosmetics or foodstuffs ; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testinginspection or research of medical treatment and technique; scientific research about health care; biology research ; computer software designcomputer programmingmaintenance of computer software; computer hardware design and development; computer software design and development
Class 44
Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
103 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/10/2025
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
11/10/2025
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
11/10/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/10/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
07/24/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/19/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/19/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/19/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/10/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/03/2022
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
06/03/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/26/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/21/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/21/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/21/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/21/2022
ES8R
TEAS SECTION 8 RECEIVED
12/16/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/21/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/21/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/21/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/21/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/11/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
08/11/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/26/2015
PUBO
PUBLISHED FOR OPPOSITION
05/26/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/06/2015
RPUB
NOA CANCELLED; REPUBLICATION REQUIRED
04/19/2015
IUCN
NOTICE OF ALLOWANCE CANCELLED
04/19/2015
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
04/03/2015
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
04/02/2015
APET
ASSIGNED TO PETITION STAFF
04/02/2015
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
03/26/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/13/2014
EX1G
SOU EXTENSION 1 GRANTED
12/11/2014
EXT1
SOU EXTENSION 1 FILED
12/11/2014
EEXT
SOU TEAS EXTENSION RECEIVED
12/11/2014
CRTP
REG. CANCELLED - RESTORED TO PENDENCY
08/25/2014
APET
ASSIGNED TO PETITION STAFF
08/20/2014
RCII
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
08/20/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2014
CHPB
POST PUBLICATION AMENDMENT - ENTERED
07/16/2014
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
07/16/2014
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/16/2014
APET
ASSIGNED TO PETITION STAFF
07/09/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/24/2014
PPAR
POST PUBLICATION AMENDMENT RECEIVED
05/14/2014
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
05/14/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/29/2014
PUBO
PUBLISHED FOR OPPOSITION
04/29/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/27/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/14/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/14/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/14/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/05/2014
GNRT
NON-FINAL ACTION E-MAILED
02/05/2014
CNRT
NON-FINAL ACTION WRITTEN
02/05/2014
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/05/2014
OTHE
CASE RETURNED TO EXAMINATION
02/04/2014
IUCN
NOTICE OF ALLOWANCE CANCELLED
02/04/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/17/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/22/2013
PUBO
PUBLISHED FOR OPPOSITION
10/22/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/02/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/18/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/17/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/22/2013
GNRT
NON-FINAL ACTION E-MAILED
03/22/2013
CNRT
NON-FINAL ACTION WRITTEN
03/22/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/19/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/18/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/18/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/28/2013
GNRT
NON-FINAL ACTION E-MAILED
02/28/2013
CNRT
NON-FINAL ACTION WRITTEN
02/28/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2013
ALIE
ASSIGNED TO LIE
02/05/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/04/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/09/2012
GNRT
NON-FINAL ACTION E-MAILED
10/09/2012
CNRT
NON-FINAL ACTION WRITTEN
10/09/2012
DOCK
ASSIGNED TO EXAMINER
10/05/2012
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
08/13/2012
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/13/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/27/2012
NWAP
NEW APPLICATION ENTERED
07/25/2012
Continuous trademark protection
Get notified about every new filing that threatens NEURIMMUNE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.